Intercept Pharma Europe Ltd.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$9.9M
Doctors Paid
3
Transactions
1,247
2024 Total
$5.9M
Payment Breakdown by Category
Research$9.9M (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9.9M | 1,247 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) | $9.9M | 3 | 1,247 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Transplant Hepatology | $17,192 | 1 | $17,192 |
| Hepatology | $17,018 | 1 | $17,018 |
| Gastroenterology | $8,272 | 1 | $8,272 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Chakradhar Reddy, M.d, M.D | Transplant Hepatology | Johnson City, TN | $17,192 | $0 |
| Mr. Federico Rodriguez Perez, Md, MD | Hepatology | San Juan, PR | $17,018 | $0 |
| Thomas Sepe, Md, MD | Gastroenterology | Providence, RI | $8,272 | $0 |
About Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. has made $9.9M in payments to 3 healthcare providers, recorded across 1,247 transactions in the CMS Open Payments database. In 2024, the company paid $5.9M. The top product by payment volume is OCALIVA ($9.9M).
Payments were distributed across 3 medical specialties. The top specialty by payment amount is Transplant Hepatology ($17,192 to 1 doctors).
Payment categories include: Research ($9.9M).